Physician profile
Isaac Halfon
NPI 1083728497
$1,081.87
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $305 · 2021: $152 · 2023: $201 · 2024: $93.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.49 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $318.98 | 2019-2020 | |
| Therapeuticsmd, INC. | $129.38 | 2019 | |
| Abbvie INC. | $123.37 | 2019 | |
| Astellas Pharma US INC | $123.10 | 2023 | Veozah |
| Pacira Pharmaceuticals Incorporated | $121.87 | 2021 | |
| Sumitomo Pharma America, INC. | $80.29 | 2023-2024 | Myfembree |
| Cook Medical LLC | $57.77 | 2021-2024 | Zilver Ptx |
| Exeltis, USA INC. | $54.63 | 2019-2024 | Slynd |
| Mayne Pharma Commercial LLC | $29.39 | 2023 | |
| Allergan, INC. | $17.11 | 2019 | |
| Myovant Sciences INC. | $13.33 | 2021 | |
| Avion Pharmaceuticals | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Halfon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.